In murine models of pneumococcal infection, passively administered human CRP has been shown to be protective against lethal pneumococcal infection, that is, CRP decreases bacteremia and enhances survival of infected mice (1, 22–26). This evidence concerns the gene CRP and pneumococcal infection.